Mergon Buys Irish Medical Specialist to Boost Global Healthcare Production
Dublin, Tuesday, 6 October 2026.
Irish manufacturer Mergon Group acquired precision injection molding specialist Inmo Tech, expanding its global capacity to produce high-margin medical device components for major pharmaceutical clients.
Acquisition Finalized in October 2026
Irish industrial manufacturer Mergon Group completed the acquisition of Inmo Tech Limited on 6 October 2026, marking a strategic expansion in the healthcare sector [1]. The deal involves a specialist manufacturer of precision injection moulded components based in Enniscrone, Co. Sligo, Ireland [1][2]. While the announcement was made on 5 October 2026, the completion date solidifies the transaction in the current fiscal period [1]. This move adds specialist injection moulding expertise and an experienced team to Mergon’s portfolio [1]. The acquisition is designed to enhance capacity to serve global medical technology clients with high-quality manufacturing [1][2].
Strategic Integration and Leadership Vision
Mergon intends to integrate Inmo Tech into its group to leverage wider engineering, automation, and product development capabilities [1]. Stéphane Maravel, CEO of Mergon Group, stated that the business is an excellent strategic fit for Mergon [1][2]. Maravel emphasized that together, the companies can build on existing strengths and create new growth opportunities [1]. Brendan Cunningham, General Manager of Inmo Tech, noted that Mergon shares a commitment to customers, quality, and technical excellence [1][2]. Cunningham added that Mergon’s scale and international experience will support the continued development of the business [2].
Global Operations and Client Base
Mergon Group is an engineering-led, global manufacturing group with operations in Ireland, USA, the Czech Republic, the UK, and Mexico [1][2]. The company serves healthcare clients including Abbott, Beckman Coulter, and Pfizer [1]. Inmo Tech will now benefit from these global manufacturing capabilities to support long-term healthcare sector growth [1]. The addition of Inmo Tech strengthens Mergon’s presence in Ireland specifically [1]. This integration allows for the utilization of Mergon’s project management and automation resources across the new entity [2].
Industry Consolidation Trends
The deal reflects a broader consolidation trend within high-margin life sciences supply chains [1]. Background reporting indicates that Mergon Group expanded its healthcare manufacturing capabilities by acquiring Inmo Tech Limited to strengthen its position within the market [3]. The plastics and medical device sectors are seeing increased focus on technical accuracy and engineering-oriented applications [3]. This transaction aligns with industry movements toward specialized technical moulding and high-quality manufacturing standards [2][3]. The completion of this deal positions the combined entity for further growth in the medical device sectors [2].